Parabilis Medicines, Inc. financial statements
Parabilis Medicines, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 145.89M | EODHD |
| Cash and equivalents | USD 27.71M | EODHD |
| Total debt | USD 58.7M | EODHD |
Parabilis Medicines, Inc. financials on 6ix · Parabilis Medicines, Inc. on 6ix